At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 46 enrolled
Drug / intervention
SCTG +2 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation
The University of Texas Health Science Center, Houston·interventional·Posted Aug 12, 2016·Updated Dec 16, 2022
In Brief
A Phase 4 clinical trial evaluating Immediate implant, SCTG, and 1 other intervention for Dental Implant and 2 related conditions. Completed, enrolled 46 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the esthetic outcomes following immediate implant combined with the autogenous tissue graft or acellular dermal matrix compared to immediate implant alone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedAug 2016
Enrollment StartOct 2016
Primary CompletionNov 2021
TodayJul 2026
First PostedAug 12, 2016
Enrollment StartOct 1, 2016
Primary CompletionNov 22, 2021
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 9.9 years ago
Interventions
Immediate implantdevice
SCTGbiological
ADMbiological